VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2023 SESSION

• | print version

HB 2200 Anti-cancer drugs; analyzing current reimbursement, etc., for medical practices that administer.

Introduced by: Roxann L. Robinson | all patrons    ...    notes | add to my profiles | history

SUMMARY AS PASSED:

License taxes; deductions; report. Directs the Secretary of Health and Human Resources to convene a work group to analyze and review current reimbursement and operational challenges for medical practices that administer anti-cancer drugs in an in-office setting. The bill requires the Secretary to report his recommendations to the Chairmen of the House Committee on Finance, the House Committee on Appropriations, the House Committee on Health, Welfare and Institutions, the Senate Committee on Finance and Appropriations, and the Senate Committee on Education and Health by November 15, 2023.

SUMMARY AS INTRODUCED:

License taxes; deductions. Provides a deduction from license taxes for anti-cancer drugs purchased by a medical practice and administered within a physician-patient relationship to patients. The exemption shall only apply to drugs that are administered to a patient whose costs for treatment are paid for by Medicare, Medicaid, or TRICARE.